Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-25-052876
Filing Date
2025-04-10
Accepted
2025-04-10 16:33:43
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A dnth_2025_proxy_notice.htm DEFA14A 24174
2 GRAPHIC img234084038_0.jpg GRAPHIC 121818
3 GRAPHIC img234084038_1.jpg GRAPHIC 45950
  Complete submission text file 0000950170-25-052876.txt   255330
Mailing Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036
Business Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036 929-999-4055
Dianthus Therapeutics, Inc. /DE/ (Filer) CIK: 0001690585 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38541 | Film No.: 25828838
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)